Lumend is a Health Care company.
LuMend Inc. designs, develops, manufactures and markets medical devices intended to enable physicians to safely, predictably and cost effectively cross Chronic Total Occlusions (CTO) in the coronary vasculature, allowing subsequent conventional guide wire placement across target stenotic lesions. The company was founded in 1996 by two pioneering interventional cardiologists, John Simpson, PhD, MD, and Matthew Selmon, MD.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 9, 2003 | Series D | $23.20M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Entrepreneur's Growth Fund | — | Series D |
Channel Medical Partners | — | Series D |